EV/EBITDA
0.01
0.000.00%
Thu, 13 Mar 2025 23:05:07 GMT
Summary
- As of March 14, 2025, RSLS EV/EBITDA is 0.01, unchanged from the previous trading day.
- Over the past year, RSLS EV/EBITDA has stayed the same.
- RSLS EV/EBITDA is now -98.91% below its all-time high of 0.92.
Performance
RSLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RSLS EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | -47.8% | -6.1% |
1 m1 month | +106.3% | -107.4% | -74.4% |
3 m3 months | +102.8% | -103.3% | -86.3% |
6 m6 months | +102.2% | -102.3% | -93.4% |
ytdytd | +103.2% | -103.8% | -84.7% |
1 y1 year | 0.0% | +0.0% | -93.7% |
5 y5 years | +100.1% | -100.0% | -100.0% |
RSLS EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.16 | +106.3% | |
3 m | 3-month | 0.01 | at high | -0.38 | +102.6% |
6 m | 6-month | 0.01 | at high | -0.50 | +102.0% |
1 y | 1-year | 0.03 | -66.7% | -0.66 | +101.5% |
3 y | 3-year | 0.21 | -95.2% | -0.66 | +101.5% |
5 y | 5-year | 0.21 | -95.2% | -8184 | +100.0% |
alltime | all time | 0.92 | -98.9% | -8184 | +100.0% |
ReShape Lifesciences EV/EBITDA History
Date | Value |
---|---|
2025 | 0.01(-103.2%) |
2024 | -0.31(+158.3%) |
2023 | -0.12(-1300.0%) |
2022 | 0.01(-110.0%) |
2021 | -0.10(-100.0%) |
Date | Value |
---|---|
2020 | -1483.09(+4917.2%) |
2019 | -29.56(-74.2%) |
2018 | -114.55(>+9900.0%) |
2017 | -0.28(-264.7%) |
2016 | 0.17 |
FAQ
- What is ReShape Lifesciences EV/EBITDA?
- What is the all time high EV/EBITDA for ReShape Lifesciences?
- What is RSLS EV/EBITDA year-to-date change?
- What is ReShape Lifesciences EV/EBITDA year-on-year change?
What is ReShape Lifesciences EV/EBITDA?
The current EV/EBITDA of RSLS is 0.01
What is the all time high EV/EBITDA for ReShape Lifesciences?
ReShape Lifesciences all-time high EV/EBITDA is 0.92
What is RSLS EV/EBITDA year-to-date change?
ReShape Lifesciences EV/EBITDA has changed by +0.32 (+103.23%) since the beginning of the year
What is ReShape Lifesciences EV/EBITDA year-on-year change?
Over the past year, RSLS EV/EBITDA has changed by 0.00 (0.00%)